Overview: The blue biotechnology market is expected to gain a market value of USD 1,180.9 million by 2030 at a CAGR of 14.3% from 2022-2030. With three-quarters of the world being covered by the sea, scientists have realized that aquatic and marine organisms can become a good source of energy and new drugs. This belief has formed the foundation of blue biotechnology. Diverse organisms in the...

Overview: The Agricultural Biotechnology Market Outlook and Analysis by Crop Type (Soybean, Maize, Cotton, and others), Application (Herbicide Tolerance, Stacked Traits, Insect Tolerance, and others), Technique (Genetic Engineering, Molecular Breeding, Molecular Diagnostics and Tissue Culture) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027...

The forecast for the Global  Agricultural Biotechnology Market indicates that it will reach USD 31.99 billion by 2027. The market's growth is primarily driven by the significant increase in population and the high demand for sufficient crop production. Factors such as crop loss, the need for higher crop yields, consumer demand for sustainably produced food, and the challenges posed by...

The antibody production market refers to the industry that produces antibodies for use in various applications, including research, diagnostics, and therapeutics. Antibodies are proteins produced by the immune system in response to an invading pathogen or foreign substance, and they can specifically bind to and neutralize these targets. In the research field, antibodies are commonly used as...

Biotechnology & Pharmaceutical Services Market Summary  Straits Research has recently added a new report to its vast depository of high-quality research reports titled Global Biotechnology & Pharmaceutical Services Market Research. The report studies vital factors about the Biotechnology & Pharmaceutical Services Market that are essential to be understood by existing and new...

According to a new report published by UnivDatos Markets Insights, the Biotechnology & Pharmaceutical Services Outsourcing Market was valued at more than USD 65 billion in 2020 and is expected to grow at a CAGR of around 5% from 2022-2028. The analysis has been segmented into services (consulting, auditing & assessment, regulatory affairs, product maintenance, product design &...

Market Summary The global market for biotechnology-based chemicals had a valuation of USD 21 billion in 2022 and is projected to reach USD 182.53 billion by 2032, experiencing a compound annual growth rate (CAGR) of 9% during the forecast period. The growth of this market is propelled by various factors including the increasing demand for bio-based chemicals, the necessity to reduce reliance on...

According to a recent report by Reports and Data, the global  biotechnology market is expected to reach USD 852.55 billion by 2030, with a revenue CAGR of 9.9% during the forecast period. The rise in demand for eco-friendly approaches to prevent pollution, conserve resources, and increase the use of biofuels is driving the growth of the market. Industrial biotechnology involves using...

Overview: The blue biotechnology market is expected to gain a market value of USD 1,180.9 million by 2030 at a CAGR of 14.3% from 2022-2030. With three-quarters of the world being covered by the sea, scientists have realized that aquatic and marine organisms can become a good source of energy and new drugs. This belief has formed the foundation of blue biotechnology. Diverse organisms in the...

Marine biotechnology, also known as blue biotechnology, facilitates the development of novel commercially viable products or applications utilizing resources from aquatic living organisms. It is a branch of research that leverages biotechnology, bioinformatics, molecular biology, and cell biology to come up with pharmaceutical medications, enzymes, and chemical goods from aquatic creatures....

With nearly two decades of experience in molecular diagnostics, biotechnology, and life sciences, Andy Moye is a leader in the fields of pathology, oncology, genomics, and precision medicine. As CEO of Paige, Andy is driving the company’s mission to advance cancer detection, patient care, and treatment through cutting-edge AI technology. Paige aims to transform cancer diagnostics by...

    Rapid growth in drug discovery and development in pharmaceutical sector, and increasing use of critter models in basic and applied research are some key factors driving market revenue growth The global critter model market size is expected to reach USD 3.15 Billion in 2030 and register a revenue CAGR of 7.6% over the forecast period, according to...